Abstract |
Human cytomegalovirus (CMV) infection is reported to promote NK cell differentiation and education. The CMV-induced generation of highly differentiated adaptive-like NK cells has been proposed to affect favorably on the maintenance of remission in patients with acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT). The impact of CMV infection and adaptive-like NK cells on relapse and survival of patients with AML not receiving allo-SCT remains unknown. We assayed CMV IgG serostatus to determine past CMV infection in 81 nontransplanted AML patients who were receiving relapse-prevention immunotherapy comprising histamine dihydrochloride and low-dose interleukin-2 (HDC/ IL2; NCT01347996). CMV seropositivity correlated negatively with leukemia-free and overall survival of patients receiving HDC/ IL2, but did not correlate with outcomes in a contemporary control cohort. Analysis of outcome after stratification of patients based on concordant or discordant killer immunoglobulin-like receptor (KIR) and HLA genotypes implied that the negative impact of CMV seropositivity was restricted to patients lacking a ligand to inhibitory KIRs (iKIR). Previous CMV infection was also associated with fewer NK cells expressing only nonself iKIRs (NS-iKIR). We propose that CMV-driven NK cell education depletes the population of NS-iKIR NK cells, which in turn reduces the clinical benefit of relapse-preventive immunotherapy in AML. Cancer Immunol Res; 6(9); 1110-9. ©2018 AACR.
|
Authors | Elin Bernson, Alexander Hallner, Frida E Sander, Malin Nicklasson, Malin S Nilsson, Karin Christenson, Ebru Aydin, Jan-Åke Liljeqvist, Mats Brune, Robin Foà, Johan Aurelius, Anna Martner, Kristoffer Hellstrand, Fredrik B Thorén |
Journal | Cancer immunology research
(Cancer Immunol Res)
Vol. 6
Issue 9
Pg. 1110-1119
(09 2018)
ISSN: 2326-6074 [Electronic] United States |
PMID | 29980537
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | ©2018 American Association for Cancer Research. |
Chemical References |
- Antibodies, Viral
- HLA Antigens
- Interleukin-2
- Receptors, KIR
- Histamine
|
Topics |
- Adolescent
- Adult
- Aged
- Antibodies, Viral
(blood)
- Cytomegalovirus
- Cytomegalovirus Infections
(immunology)
- Female
- HLA Antigens
(genetics)
- Histamine
(therapeutic use)
- Humans
- Immunotherapy
- Interleukin-2
(therapeutic use)
- Killer Cells, Natural
(immunology)
- Leukemia, Myeloid, Acute
(immunology, therapy)
- Male
- Middle Aged
- Receptors, KIR
(genetics)
- Young Adult
|